DRAM研发设计制造
Search documents
首家预先审阅IPO获受理!长鑫科技295亿!预计 2026 年或 2027 年可实现盈利
梧桐树下V· 2025-12-31 02:41
Core Viewpoint - Changxin Technology Group Co., Ltd. has been accepted for IPO on the Sci-Tech Innovation Board, aiming to raise 29.5 billion yuan, marking it as the first project to undergo pre-review before acceptance [1][2]. Company Overview - Changxin Technology, established in June 2016 and transformed into a joint-stock company in June 2023, is the largest and most advanced DRAM R&D and manufacturing enterprise in China, with a registered capital of 60.1928 billion yuan [3]. - The company has achieved international advanced levels in its core products and technology, focusing on DRAM products since its inception [3]. Financial Performance - The company reported revenues of 8.28654 billion yuan in 2022, 9.08715 billion yuan in 2023, 24.17825 billion yuan in 2024, and 15.43792 billion yuan in the first half of 2025 [5]. - The net profit attributable to the parent company for the same periods was -8.62586 billion yuan, -16.75200 billion yuan, -7.87003 billion yuan, and -2.38654 billion yuan respectively [5]. Revenue Composition - The revenue composition for the first half of 2025 shows that DDR series contributed 27.82%, LPDDR series contributed 69.74%, and other products and services contributed 2.44% [3]. Shareholding Structure - The company has a dispersed shareholding structure with no controlling shareholder or actual controller, with the largest shareholder holding 21.67% [4]. Future Projections - For 2025, the company expects revenues between 55 billion and 58 billion yuan, representing a year-on-year growth of 127.48% to 139.89% [6][7]. - The company anticipates achieving profitability in 2026 or 2027, contingent on average selling prices and monthly shipment volumes [7]. R&D Investment - From 2022 to 2024, the company invested a total of 15.20675 billion yuan in R&D, accounting for 36.60% of its cumulative revenue during this period [8][9]. - As of June 30, 2025, the company held 3,116 domestic patents and 2,473 foreign patents, with over seven patents applicable to its main business [8][9]. Major Clients and Suppliers - The top five clients accounted for 69.43% to 59.99% of the company's revenue during the reporting periods, with no single client exceeding 50% of total revenue [10][11]. - The top five suppliers contributed between 24.42% and 31.39% to the total raw material procurement costs [11]. IPO Fund Utilization - The IPO proceeds of 29.5 billion yuan will be allocated to three projects: upgrading the wafer manufacturing line, DRAM technology upgrades, and advanced R&D projects [12].